Current Opinion in Rheumatology
Risks of Immunosuppressive Therapies Including Biologic Agents in Patients With Rheumatic Diseases and Co-Existing Chronic Viral Infections CME

Disclosures

Release Date: February 29, 2008; Valid for credit through March 1, 2009
Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians

Contents of This CME Activity
    To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.
    Risks of Immunosuppressive Therapies Including Biologic Agents in Patients With Rheumatic Diseases and Co-Existing Chronic Viral Infections
    Dimitrios Vassilopoulos, MD
    Leonard H. Calabrese, DO

Go to Test Questions

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2008 Medscape.

 
WebMD
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Identify biologic agents used for immunosuppression with different actions and targets
  2. Describe the clinical presentation of progressive multifocal leukoencephalopathy
  3. List factors that predispose to reactivation of hepatitis B infection in immunosuppressed patients
  4. Describe the lifetime risk for herpes zoster virus infection in patients with rheumatoid arthritis and systemic lupus erythematosus compared with the general population
  5. Identify the hazard ratio for risk for herpes zoster infection associated with the use of different immunosuppressive agents
Authors and Disclosures

Dimitrios Vassilopoulos, MD
Disclosure: Dimitrios Vassilopoulos, MD, has disclosed no relevant financial relationships.


Leonard H. Calabrese, DO
Disclosure: Leonard H. Calabrese, DO, has disclosed no relevant financial relationships.


Désirée Lie, MD, MSEd
Disclosure: Désirée Lie, MD, MSEd, has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.